$4.94 -0.03 (-0.61%)
11/25/2009 4:00 PM

Cytori Therapeutics, Inc. (USA) (CYTX)

CAPS Rating: 4 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Featured Broker Partners